UroGen Pharma (URGN) announced that adult patients living with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer now have improved access to an important therapy, as the ...

BCD Meetings & Incentives last week launched an EMEA-wide Pharmaceutical Code Compliance Team to reassure clients it operates within the strict requirements governing meetings staged by pharmaceutical ...

After Novo Nordisk breached not one, not two, but seven clauses of the code that regulates U.K. drugmakers, its U.K. general manager is stepping down as president of the industry's national ...

Faced with growing criticism and increased regulation, the pharmaceutical industry has adopted a new code of ethics. Will this self-policing policy increase consumer safety, improve the industry’s ...